Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Brotizolam: a sleep laboratory evaluation.

A Vela-Bueno, J C Oliveros, B Dobladez-Blanco

    European Journal of Clinical Pharmacology
    |January 1, 1983
    PubMed
    Summary

    Brotizolam (0.25 mg) improved sleep duration in normal subjects. However, rebound anxiety and increased wakefulness were observed during withdrawal, indicating potential side effects of this hypnotic medication.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Selective Pressure by Rifampicin Modulates Mutation Rates and Evolutionary Trajectories of Mycobacterial Genomes.

    Microbiology spectrum·2023
    Same author

    [Sleep and academic performance in university students: a systematic review].

    Revista de neurologia·2020
    Same author

    Hypothalamus-pituitary-adrenal (HPA) axis parameters and neurocognitive evaluation in patients with bipolar disorder.

    Psychiatrike = Psychiatriki·2019
    Same author

    Environmental factors in the development of narcolepsy with cataplexy. A case-control study.

    Revista de neurologia·2015
    Same author

    A reassessment of triazolam.

    The International journal of risk & safety in medicine·2013
    Same author

    [A study of irritability in menopausal women].

    Psychiatrike = Psychiatriki·2012

    Area of Science:

    • Pharmacology
    • Sleep Medicine
    • Clinical Trials

    Background:

    • Insomnia is a prevalent sleep disorder affecting millions worldwide.
    • Hypnotic medications are commonly prescribed to manage insomnia.
    • Understanding the efficacy and withdrawal effects of hypnotics like brotizolam is crucial for patient care.

    Purpose of the Study:

    • To evaluate the efficacy and safety of brotizolam 0.25 mg in a controlled sleep laboratory setting.
    • To assess the initial effects, side effects, and withdrawal phenomena associated with brotizolam use.

    Main Methods:

    • A double-blind, placebo-controlled study was conducted over 10 consecutive nights.
    • Ten healthy subjects participated, with phases including placebo-baseline, drug administration, and placebo-withdrawal.

    Related Experiment Videos

  • Sleep parameters and subjective anxiety levels were monitored.

    • Main Results:

    • Brotizolam significantly increased total sleep time, primarily in the early part of the night.
    • Daytime anxiety/tension increased during drug administration, suggesting rebound anxiety.
    • Total wake time significantly increased by 40% above baseline during the first and third nights of drug withdrawal.

    Conclusions:

    • Brotizolam 0.25 mg demonstrates hypnotic efficacy by increasing sleep time.
    • Potential side effects include rebound anxiety and significant insomnia upon withdrawal.
    • Careful consideration of withdrawal symptoms is necessary when prescribing brotizolam.